Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists - PubMed (original) (raw)
Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists
P S Portoghese et al. Life Sci. 1987.
Abstract
The opioid antagonist activities of two bivalent ligands, BNI and nor-BNI, have been evaluated in smooth muscle preparations and in mice. Both ligands are highly potent and selective as kappa opioid receptor antagonists, with relatively feeble blocking activity at mu and delta opioid receptors. BNI and nor-BNI represent the first highly selective kappa opioid receptor antagonists and should be of great utility as molecular probes for identifying the interaction of agonist ligands with kappa opioid receptors in vitro and in vivo.
Similar articles
- Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.
Takemori AE, Ho BY, Naeseth JS, Portoghese PS. Takemori AE, et al. J Pharmacol Exp Ther. 1988 Jul;246(1):255-8. J Pharmacol Exp Ther. 1988. PMID: 2839664 - Only one pharmacophore is required for the kappa opioid antagonist selectivity of norbinaltorphimine.
Portoghese PS, Nagase H, Takemori AE. Portoghese PS, et al. J Med Chem. 1988 Jul;31(7):1344-7. doi: 10.1021/jm00402a015. J Med Chem. 1988. PMID: 2838632 - TENA, a selective kappa opioid receptor antagonist.
Portoghese PS, Takemori AE. Portoghese PS, et al. Life Sci. 1985 Feb 25;36(8):801-5. doi: 10.1016/0024-3205(85)90202-4. Life Sci. 1985. PMID: 2983171 - Endorphins and food intake: kappa opioid receptor agonists and hyperphagia.
Cooper SJ, Jackson A, Kirkham TC. Cooper SJ, et al. Pharmacol Biochem Behav. 1985 Nov;23(5):889-901. doi: 10.1016/0091-3057(85)90088-7. Pharmacol Biochem Behav. 1985. PMID: 2867562 Review. - Kappa receptor bivalent ligands.
Peng X, Neumeyer JL. Peng X, et al. Curr Top Med Chem. 2007;7(4):363-73. doi: 10.2174/156802607779941251. Curr Top Med Chem. 2007. PMID: 17305578 Review.
Cited by
- The opioid receptor: emergence through millennia of pharmaceutical sciences.
Fairbanks CA, Peterson CD. Fairbanks CA, et al. Front Pain Res (Lausanne). 2023 Nov 1;4:960389. doi: 10.3389/fpain.2023.960389. eCollection 2023. Front Pain Res (Lausanne). 2023. PMID: 38028425 Free PMC article. Review. - Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design.
Broad J, Maurel D, Kung VW, Hicks GA, Schemann M, Barnes MR, Kenakin TP, Granier S, Sanger GJ. Broad J, et al. Sci Rep. 2016 Aug 5;6:30797. doi: 10.1038/srep30797. Sci Rep. 2016. PMID: 27492592 Free PMC article. - Peripheral analgesic activities of peptides related to alpha-melanocyte stimulating hormone and interleukin-1 beta 193-195.
Poole S, Bristow AF, Lorenzetti BB, Das RE, Smith TW, Ferreira SH. Poole S, et al. Br J Pharmacol. 1992 Jun;106(2):489-92. doi: 10.1111/j.1476-5381.1992.tb14361.x. Br J Pharmacol. 1992. PMID: 1327383 Free PMC article. - Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test.
Lutfy K, Maidment NT. Lutfy K, et al. Br J Pharmacol. 2000 Dec;131(8):1684-8. doi: 10.1038/sj.bjp.0703746. Br J Pharmacol. 2000. PMID: 11139447 Free PMC article. - In vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel mu opioid analgesic with reduced propensity to alter motor function.
Spetea M, Bohotin CR, Asim MF, Stübegger K, Schmidhammer H. Spetea M, et al. Eur J Pharm Sci. 2010 Sep 11;41(1):125-35. doi: 10.1016/j.ejps.2010.05.018. Epub 2010 Jun 18. Eur J Pharm Sci. 2010. PMID: 20600882 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials